ALNYLAM PHARMACEUTICALS INC's ticker is and the CUSIP is 02043Q957. A total of 6 filers reported holding ALNYLAM PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,084,000 | -25.4% | 40,000 | -20.0% | 0.00% | 0.0% |
| Q2 2023 | $9,497,000 | -5.2% | 50,000 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $10,016,000 | +105265.0% | 50,000 | +25.0% | 0.00% | 0.0% |
| Q4 2022 | $9,506 | -99.5% | 40,000 | +236.1% | 0.00% | – |
| Q2 2022 | $1,736,000 | -8.3% | 11,900 | +2.6% | 0.00% | – |
| Q1 2022 | $1,894,000 | -86.6% | 11,600 | -86.1% | 0.00% | -100.0% |
| Q4 2021 | $14,126,000 | +138.1% | 83,300 | +138.0% | 0.00% | +100.0% |
| Q2 2021 | $5,933,000 | +172.5% | 35,000 | +75.0% | 0.00% | 0.0% |
| Q1 2020 | $2,177,000 | +29.4% | 20,000 | +11.1% | 0.00% | – |
| Q1 2019 | $1,682,000 | -35.9% | 18,000 | -40.0% | 0.00% | -100.0% |
| Q3 2018 | $2,626,000 | -1.2% | 30,000 | +11.1% | 0.00% | 0.0% |
| Q2 2018 | $2,659,000 | -17.3% | 27,000 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $3,216,000 | – | 27,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BOOTHBAY FUND MANAGEMENT, LLC | 57 | $741,000 | 0.03% |
| GROUP ONE TRADING, L.P. | 27,700 | $3,600,000 | 0.01% |
| SIMPLEX TRADING, LLC | 104 | $1,351,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |